ARCHIVES

DCT Advisors Approve Increased Spending On Trials Monitoring

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994

In Brief: Cancer Series Helps Do In Woodward As Post Metro Editor; OCC RFP Canceled, to Reappear As 4-5 RFPs

January 15, 1982

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010